What does CUSIP 88339KAA0 represent in this 13F holders report?

CUSIP 88339KAA0 is the security identifier for 88339KAA0 - THERAVANCE BIOPHARMA INC - NOTE 3.250%11/0 used to aggregate holder disclosures.

How many institutions held 88339KAA0 - THERAVANCE BIOPHARMA INC - NOTE 3.250%11/0 in Q4 2019?

24 institutional investors reported 88339KAA0 - THERAVANCE BIOPHARMA INC - NOTE 3.250%11/0 for Q4 2019. Use the holders table for investor-level position and value details.

THERAVANCE BIOPHARMA INC - NOTE 3.250%11/0

CUSIP: 88339KAA0

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class: Debt / NOTE 3.250%11/0
Market price (% of par): 103.64%
Total 13F principal: $236,117,000
Principal change: +$500,000
Total reported market value: $241,820,000
Number of holders: 24
Value change: -$420,323
Number of buys: 6
Number of sells: 4

Quarterly Holders Quick Answers

What is CUSIP 88339KAA0?
CUSIP 88339KAA0 identifies 88339KAA0 - THERAVANCE BIOPHARMA INC - NOTE 3.250%11/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2020
Previous quarter: Q3 2019

Recent filing periods for CUSIP 88339KAA0:

Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020

Institutional Holders of THERAVANCE BIOPHARMA INC - NOTE 3.250%11/0 as of Q4 2019

As of 31 Dec 2019, THERAVANCE BIOPHARMA INC - NOTE 3.250%11/0 was held by 24 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $236,117,000 in principal (par value) of the bond. The largest 10 bondholders included CITADEL ADVISORS LLC, BAUPOST GROUP LLC/MA, Kohlberg Kravis Roberts & Co. L.P., WOLVERINE ASSET MANAGEMENT LLC, DeepCurrents Investment Group LLC, ZAZOVE ASSOCIATES LLC, Verition Fund Management LLC, Context Capital Management, LLC, Linden Advisors LP, and Castle Creek Arbitrage, LLC. This page lists 24 institutional bondholders reporting positions for the Q4 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price (% of par)	Principal	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.